Thu, Oct 17 3:50am


NASDAQ: GWPH $4 Billion Mid-Cap. Drug Manufacturers industry. 5 Year Return 76%. 1 Year Return 18%. 2019 YTD Return 19%. Earnings in 19 days on Tue, Nov 5. (Use the Earnings tab below to add this date to your calendar.)

GWPH Profile

Market Cap 4 Billion
GWPH Description

GW Pharmaceuticals PLC is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. Its business activities are functioned through three reportable segments which are Commercial, Sativex Research and Development and Pipeline Research and Development. The company's lead product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol used for the treatment of a number of rare childhood-onset epilepsy disorders. The company also develops and markets Sativex, an oromucosal spray for the treatment of spasticity due to multiple sclerosis. Geographically its presence can be seen across the region of UK, Europe, US, Canada, and others.

Visit Website

GWPH Earnings

EPS 2.52 P/E Ratio 0.00
Previous Tue, Aug 6, 2019
Latest Tue, Nov 5, 2019 (In 19 days)

GWPH Dividend

Yield --
Ex-Date --
Pay Date --
History --

GWPH Charts

1 Year
Dec 27, 2018
May 7, 2019

Symbol Price Day Ξ” YTD Ξ”
GWPH $119.86 -0.39% 18.66%


Symbol Surfing

How can we make Symbol Surfing better?

©2019 Symbol Surfing All Rights Reserved.

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Cookies Policy | Terms Of Service | Privacy Policy